Misfolded Proteins: ND

Protein misfolding is the primary cause of several neurodegenerative disease, including Alzheimer’s and Parkinson’s disease. Here is the latest research.

May 21, 2020
Open Access

A game-theoretic approach to deciphering the dynamics of amyloid-β aggregation along competing pathways

Royal Society Open Science
Preetam GhoshAshwin Vaidya
May 26, 2020

The HSP110/HSP70 disaggregation system generates spreading-competent toxic α-synuclein species

The EMBO Journal
Jessica TittelmeierCarmen Nussbaum-Krammer
May 22, 2020

Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation

Brain : a Journal of Neurology
Eiko N MinakawaYoshitaka Nagai
June 2, 2020
Review

Pharmacological exploration of traditional plants for the treatment of neurodegenerative disorders

Phytotherapy Research : PTR
Muqeet WahidMuhammad Hassham Hassan Bin Asad
May 29, 2020
Review

Neuron-Glia interaction: Molecular basis of Alzheimer's Disease and Applications of Neuroproteomics

The European Journal of Neuroscience
Abdallah Mohammad IbrahimJb Senthil Kumar
June 2, 2020

Fluorogenic detection of protein aggregates in live cells using the AggTag method

Methods in Enzymology
Kwan Ho Jung, Xin Zhang
June 2, 2020

Emerging Proof of Protein Misfolding and Interaction in Multifactorial Alzheimer's Disease

Current Topics in Medicinal Chemistry
Md Sahab UddinGhulam Md Ashraf
May 30, 2020

Therapeutic Effects of Melatonin-Treated Bone Marrow Mesenchymal Stem Cells (BMSC) in a Rat Model of Alzheimer's Disease

Journal of Chemical Neuroanatomy
Mahdi RamezaniZoleikha Golipoor
May 30, 2020

Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases

Advances in Experimental Medicine and Biology
Vasiliki Machairaki
May 30, 2020

Alzheimer's Disease Therapeutic Approaches

Advances in Experimental Medicine and Biology
Maria Revi
June 2, 2020

Method to discriminate amyloids using fluorescent probes

Methods in Enzymology
Kristine L TeppangJerry Yang
May 28, 2020
Open Access

Partial reduction of amyloid β production by β-secretase inhibitors does not decrease synaptic transmission

Alzheimer's Research & Therapy
Tugce Munise SatirHenrik Zetterberg
June 2, 2020
Review
Open Access

Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer's Disease

Frontiers in Aging Neuroscience
Yunying Yang, Zhentao Zhang
May 19, 2020

Interlink between insulin resistance and neurodegeneration with an update on current therapeutic approaches

CNS & Neurological Disorders Drug Targets
Subrat Kumar BhattamisraHira Choudhury
May 30, 2020
Review

Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer's Disease

Cellular and Molecular Neurobiology
Shwetha NanjundaiahSubashchandrabose Chinnathambi
May 23, 2020
Review

Evidence of distinct α-synuclein strains underlying disease heterogeneity

Acta Neuropathologica
Sara A M Holec, Amanda L Woerman

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/misfolded-proteins-nd/2188d755-1ef3-4cfc-8f49-f4478c3104e5